CRSP Stock On Wild Ride After FDA's Historic Approval. These Gene Editing Treatments Could Be Next.
112,574
Published 2023-12-08
Government approval of these groundbreaking treatments could generate an unprecedented wave of medical innovation. But gene editing therapies aren’t without risk, and questions remain about the safety and cost effectiveness of these experimental treatments.
On this episode of Growth Stories, we dive into the science of gene editing treatments and how the boom in gene therapy drug approvals could transform the healthcare industry.
SUBSCRIBE ► bit.ly/3x9SKsm
Visit our website ► investors.com
Follow me on Twitter ► twitter.com/IBD_Alexis
Questions, comments, suggestions? Drop them in the comment box below. Thanks for watching!
#AlexisGarcia #IBD #InvestorsBusinessDaily
All Comments (21)
-
I wonder how many members of congress and the FDA just happened to own the stock…
-
3.5million per treatment... Is there a cure for greed yet?
-
Let's be clear, the cost of producing these therapies, now that the foundational scientific research is complete, amounts to only a few dollars. The million-dollar price tags attached to them are not even intended to recover research and development costs, which have been partially funded through taxpayer-supported academic institutions, philanthropic donations, and the dedicated work of scientists. Rather, these extraordinary price tags are driven by pharmaceutical companies' focus on profits over people. Each person cured means one less source of ongoing revenue. Let that sink in - cures destroy repeat business.
-
GOLDEN age for modern medicine alright with emphasis on GOLDEN. More like golden age for curing and perfecting rich people.
-
i know all about this, but great video Alexis. i hope you spread knowledge and hope to more people.
-
The discovery stage of CRISPR that goes from its study as a biological phenomenon to its conception as a mechanism that can be used as a genomic editing tool took place mainly in American universities with public funding from federal agencies such as the Department of Energy and the National Science Foundation.Feb 7, 2023
-
I feel investors should be focusing on under-the-radar stocks, and considering the current rollercoaster nature of the stock market, Because 35% of my $270k portfolio comprises of plummeting stocks which were once revered and i don't know where to go here out of devastation.
-
We could just invest in preventing illnesses, but that would hurt corporate profits and there’s no market for that.
-
👏🏼👏🏼. Great video … very informative yet concise.
-
Aging is another big killer
-
Energy will flow more ,Clean more cells live longer, create a Larger Magnetic Field, Keep going
-
I wish humans could code genes just like in programming language. Wish humans could reset genetic code into "default" and remove all errors caused by mutations from pollution,chemicals, stress and etc...
-
It has taken a long time for gene therapy to actually work. I wonder when it will treat common chronic diseases.
-
If I understood it correctly, he had to get chemo before the gene editing? So will we get better methods of treatment that don’t involve chemo as a prerequisite?
-
At least 15,000 patients across the world have received CAR T cells, and dozens more clinical trials using this approach are in progress, Six treatments are fully FDA approved. Success averages 55 to 65% across the board. The modified cells don't last long.
-
I'm actually happy my covid shot helped others. I knew it would but I had no idea how much.
-
How come no one cares to mention the ultimate goal and holy grail of gene therapy, longevity?
-
This could be wonderful! Rarely do medical co do cures just continual treatments & prescriptions
-
The World Will Never Be Same As The Human beings Will Be Changed For Ever
-
Cool breakthrough
